nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—PLA2G1B—Betamethasone—multiple sclerosis	0.267	0.347	CbGbCtD
Sulfasalazine—PLA2G1B—Dexamethasone—multiple sclerosis	0.155	0.202	CbGbCtD
Sulfasalazine—SLC46A1—Methotrexate—multiple sclerosis	0.125	0.162	CbGbCtD
Sulfasalazine—ABCG2—Cladribine—multiple sclerosis	0.0389	0.0506	CbGbCtD
Sulfasalazine—PTGS2—Triamcinolone—multiple sclerosis	0.0322	0.0419	CbGbCtD
Sulfasalazine—ABCG2—Mitoxantrone—multiple sclerosis	0.0284	0.0369	CbGbCtD
Sulfasalazine—PTGS2—Betamethasone—multiple sclerosis	0.0276	0.036	CbGbCtD
Sulfasalazine—ABCC2—Dexamethasone—multiple sclerosis	0.0163	0.0212	CbGbCtD
Sulfasalazine—PTGS2—Dexamethasone—multiple sclerosis	0.0161	0.0209	CbGbCtD
Sulfasalazine—SLCO1B1—Methotrexate—multiple sclerosis	0.0149	0.0194	CbGbCtD
Sulfasalazine—ABCG2—Dexamethasone—multiple sclerosis	0.0147	0.0191	CbGbCtD
Sulfasalazine—ABCC2—Methotrexate—multiple sclerosis	0.0131	0.017	CbGbCtD
Sulfasalazine—ABCG2—Methotrexate—multiple sclerosis	0.0118	0.0154	CbGbCtD
Sulfasalazine—TBXAS1—leg—multiple sclerosis	0.0109	0.179	CbGeAlD
Sulfasalazine—CYP3A5—Dexamethasone—multiple sclerosis	0.00815	0.0106	CbGbCtD
Sulfasalazine—PPARG—leg—multiple sclerosis	0.00412	0.0676	CbGeAlD
Sulfasalazine—Olsalazine—IFNG—multiple sclerosis	0.00279	0.865	CrCbGaD
Sulfasalazine—ACAT1—medulla oblongata—multiple sclerosis	0.00213	0.0349	CbGeAlD
Sulfasalazine—PTGS2—leg—multiple sclerosis	0.00211	0.0346	CbGeAlD
Sulfasalazine—ACAT1—midbrain—multiple sclerosis	0.00194	0.0319	CbGeAlD
Sulfasalazine—ACAT1—spinal cord—multiple sclerosis	0.0019	0.0311	CbGeAlD
Sulfasalazine—ACAT1—nervous system—multiple sclerosis	0.0016	0.0262	CbGeAlD
Sulfasalazine—ACAT1—central nervous system—multiple sclerosis	0.00154	0.0252	CbGeAlD
Sulfasalazine—ACAT1—cerebellum—multiple sclerosis	0.0015	0.0247	CbGeAlD
Sulfasalazine—SLC46A1—spinal cord—multiple sclerosis	0.00141	0.0232	CbGeAlD
Sulfasalazine—TBXAS1—nervous system—multiple sclerosis	0.00134	0.0219	CbGeAlD
Sulfasalazine—TBXAS1—central nervous system—multiple sclerosis	0.00129	0.0211	CbGeAlD
Sulfasalazine—ACAT1—brain—multiple sclerosis	0.00122	0.02	CbGeAlD
Sulfasalazine—SLC7A11—midbrain—multiple sclerosis	0.00119	0.0196	CbGeAlD
Sulfasalazine—SLC46A1—nervous system—multiple sclerosis	0.00119	0.0195	CbGeAlD
Sulfasalazine—SLC7A11—spinal cord—multiple sclerosis	0.00116	0.0191	CbGeAlD
Sulfasalazine—SLC46A1—central nervous system—multiple sclerosis	0.00115	0.0188	CbGeAlD
Sulfasalazine—SLC46A1—cerebellum—multiple sclerosis	0.00112	0.0184	CbGeAlD
Sulfasalazine—CHUK—cerebellum—multiple sclerosis	0.00112	0.0184	CbGeAlD
Sulfasalazine—PLA2G1B—nervous system—multiple sclerosis	0.00112	0.0184	CbGeAlD
Sulfasalazine—PLA2G1B—central nervous system—multiple sclerosis	0.00108	0.0177	CbGeAlD
Sulfasalazine—TBXAS1—brain—multiple sclerosis	0.00102	0.0167	CbGeAlD
Sulfasalazine—SLC7A11—nervous system—multiple sclerosis	0.00098	0.0161	CbGeAlD
Sulfasalazine—SLC7A11—central nervous system—multiple sclerosis	0.000944	0.0155	CbGeAlD
Sulfasalazine—SLC7A11—cerebellum—multiple sclerosis	0.000922	0.0151	CbGeAlD
Sulfasalazine—SLC46A1—brain—multiple sclerosis	0.00091	0.0149	CbGeAlD
Sulfasalazine—CHUK—brain—multiple sclerosis	0.00091	0.0149	CbGeAlD
Sulfasalazine—PLA2G1B—brain—multiple sclerosis	0.000855	0.014	CbGeAlD
Sulfasalazine—IKBKB—nervous system—multiple sclerosis	0.000809	0.0133	CbGeAlD
Sulfasalazine—IKBKB—central nervous system—multiple sclerosis	0.000779	0.0128	CbGeAlD
Sulfasalazine—IKBKB—cerebellum—multiple sclerosis	0.000761	0.0125	CbGeAlD
Sulfasalazine—SLC7A11—brain—multiple sclerosis	0.000749	0.0123	CbGeAlD
Sulfasalazine—ALOX5—nervous system—multiple sclerosis	0.000671	0.011	CbGeAlD
Sulfasalazine—ALOX5—central nervous system—multiple sclerosis	0.000646	0.0106	CbGeAlD
Sulfasalazine—ALOX5—cerebellum—multiple sclerosis	0.000631	0.0104	CbGeAlD
Sulfasalazine—IKBKB—brain—multiple sclerosis	0.000618	0.0101	CbGeAlD
Sulfasalazine—ALOX5—brain—multiple sclerosis	0.000513	0.00841	CbGeAlD
Sulfasalazine—PPARG—nervous system—multiple sclerosis	0.000503	0.00826	CbGeAlD
Sulfasalazine—PPARG—central nervous system—multiple sclerosis	0.000485	0.00795	CbGeAlD
Sulfasalazine—Vismodegib—ALB—multiple sclerosis	0.000434	0.135	CrCbGaD
Sulfasalazine—ABCG2—medulla oblongata—multiple sclerosis	0.00043	0.00705	CbGeAlD
Sulfasalazine—ABCG2—midbrain—multiple sclerosis	0.000393	0.00644	CbGeAlD
Sulfasalazine—PPARG—brain—multiple sclerosis	0.000385	0.00631	CbGeAlD
Sulfasalazine—ABCG2—spinal cord—multiple sclerosis	0.000383	0.00628	CbGeAlD
Sulfasalazine—PTGS2—medulla oblongata—multiple sclerosis	0.000342	0.00562	CbGeAlD
Sulfasalazine—PTGS1—spinal cord—multiple sclerosis	0.000319	0.00524	CbGeAlD
Sulfasalazine—PTGS2—midbrain—multiple sclerosis	0.000313	0.00513	CbGeAlD
Sulfasalazine—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.000308	0.0716	CbGdCrCtD
Sulfasalazine—PTGS2—spinal cord—multiple sclerosis	0.000305	0.00501	CbGeAlD
Sulfasalazine—ABCG2—cerebellum—multiple sclerosis	0.000304	0.00498	CbGeAlD
Sulfasalazine—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.000304	0.0704	CbGdCrCtD
Sulfasalazine—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.000304	0.0704	CbGdCrCtD
Sulfasalazine—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.000297	0.0688	CbGdCrCtD
Sulfasalazine—PTGS1—nervous system—multiple sclerosis	0.000269	0.00442	CbGeAlD
Sulfasalazine—PTGS1—central nervous system—multiple sclerosis	0.000259	0.00425	CbGeAlD
Sulfasalazine—PTGS2—nervous system—multiple sclerosis	0.000257	0.00422	CbGeAlD
Sulfasalazine—SLC7A11—Dexamethasone—Methylprednisolone—multiple sclerosis	0.000249	0.0578	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Methylprednisolone—multiple sclerosis	0.000249	0.0578	CbGdCrCtD
Sulfasalazine—PTGS2—central nervous system—multiple sclerosis	0.000248	0.00406	CbGeAlD
Sulfasalazine—ABCG2—brain—multiple sclerosis	0.000247	0.00405	CbGeAlD
Sulfasalazine—SLC7A11—Betamethasone—Dexamethasone—multiple sclerosis	0.000245	0.0569	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Betamethasone—multiple sclerosis	0.000245	0.0569	CbGdCrCtD
Sulfasalazine—PTGS2—cerebellum—multiple sclerosis	0.000242	0.00397	CbGeAlD
Sulfasalazine—SLC7A11—Betamethasone—Triamcinolone—multiple sclerosis	0.00024	0.0556	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Triamcinolone—multiple sclerosis	0.00024	0.0556	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Prednisone—multiple sclerosis	0.000227	0.0528	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Prednisone—multiple sclerosis	0.000227	0.0528	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Prednisolone—multiple sclerosis	0.000222	0.0515	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Prednisolone—multiple sclerosis	0.000222	0.0515	CbGdCrCtD
Sulfasalazine—PTGS1—brain—multiple sclerosis	0.000206	0.00338	CbGeAlD
Sulfasalazine—PTGS2—brain—multiple sclerosis	0.000197	0.00323	CbGeAlD
Sulfasalazine—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000186	0.0432	CbGdCrCtD
Sulfasalazine—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000183	0.0425	CbGdCrCtD
Sulfasalazine—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000183	0.0425	CbGdCrCtD
Sulfasalazine—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.000179	0.0415	CbGdCrCtD
Sulfasalazine—CHUK—Immune System—CCR2—multiple sclerosis	2.15e-05	0.000132	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—GPR65—multiple sclerosis	2.14e-05	0.000131	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—TLR4—multiple sclerosis	2.12e-05	0.00013	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	2.12e-05	0.000129	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—RRM1—multiple sclerosis	2.11e-05	0.000129	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—multiple sclerosis	2.08e-05	0.000127	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—IL6—multiple sclerosis	2.08e-05	0.000127	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—IL6—multiple sclerosis	2.08e-05	0.000127	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-DPB1—multiple sclerosis	2.08e-05	0.000127	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	2.08e-05	0.000127	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	2.08e-05	0.000127	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—STAT3—multiple sclerosis	2.07e-05	0.000126	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—IL6—multiple sclerosis	2.07e-05	0.000126	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—IL6—multiple sclerosis	2.05e-05	0.000125	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—HLA-DRB1—multiple sclerosis	2.04e-05	0.000125	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—IL6—multiple sclerosis	2.04e-05	0.000125	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—POMC—multiple sclerosis	2.04e-05	0.000125	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—STAT3—multiple sclerosis	2.03e-05	0.000124	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CD28—multiple sclerosis	2.03e-05	0.000124	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HLA-A—multiple sclerosis	2.02e-05	0.000124	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GPC5—multiple sclerosis	2.02e-05	0.000124	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.01e-05	0.000123	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—IL6—multiple sclerosis	2e-05	0.000123	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD40—multiple sclerosis	2e-05	0.000123	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—ITGA4—multiple sclerosis	2e-05	0.000123	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—TYK2—multiple sclerosis	2e-05	0.000122	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD28—multiple sclerosis	1.99e-05	0.000122	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IFNB1—multiple sclerosis	1.99e-05	0.000122	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CTLA4—multiple sclerosis	1.97e-05	0.000121	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CD80—multiple sclerosis	1.96e-05	0.00012	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CXCL13—multiple sclerosis	1.96e-05	0.00012	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCR1—multiple sclerosis	1.96e-05	0.00012	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—ICAM1—multiple sclerosis	1.96e-05	0.00012	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PTPRC—multiple sclerosis	1.95e-05	0.00012	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CCR2—multiple sclerosis	1.95e-05	0.00012	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—TLR4—multiple sclerosis	1.93e-05	0.000118	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GPC5—multiple sclerosis	1.9e-05	0.000116	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—multiple sclerosis	1.89e-05	0.000116	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-DPB1—multiple sclerosis	1.89e-05	0.000116	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD80—multiple sclerosis	1.88e-05	0.000115	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—MAPK1—multiple sclerosis	1.88e-05	0.000115	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—STAT3—multiple sclerosis	1.87e-05	0.000115	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—ALB—multiple sclerosis	1.86e-05	0.000114	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HLA-DRB1—multiple sclerosis	1.85e-05	0.000113	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—MAPK1—multiple sclerosis	1.85e-05	0.000113	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—multiple sclerosis	1.85e-05	0.000113	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—STAT3—multiple sclerosis	1.84e-05	0.000113	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.84e-05	0.000113	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.83e-05	0.000112	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—ITGA4—multiple sclerosis	1.82e-05	0.000111	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD40—multiple sclerosis	1.82e-05	0.000111	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—STAT3—multiple sclerosis	1.81e-05	0.000111	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IFNB1—multiple sclerosis	1.8e-05	0.00011	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CTLA4—multiple sclerosis	1.79e-05	0.00011	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CD80—multiple sclerosis	1.78e-05	0.000109	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—ICAM1—multiple sclerosis	1.77e-05	0.000109	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—VCAM1—multiple sclerosis	1.74e-05	0.000107	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-DQA1—multiple sclerosis	1.74e-05	0.000106	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—BCHE—multiple sclerosis	1.73e-05	0.000106	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD80—multiple sclerosis	1.71e-05	0.000104	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	1.71e-05	0.000104	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—MAPK1—multiple sclerosis	1.7e-05	0.000104	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—MYC—multiple sclerosis	1.68e-05	0.000103	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—APOE—multiple sclerosis	1.68e-05	0.000103	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—TGFB1—multiple sclerosis	1.68e-05	0.000103	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—MAPK1—multiple sclerosis	1.68e-05	0.000102	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—RRM1—multiple sclerosis	1.67e-05	0.000102	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—VDR—multiple sclerosis	1.67e-05	0.000102	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—TYK2—multiple sclerosis	1.66e-05	0.000101	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—MAPK1—multiple sclerosis	1.65e-05	0.000101	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.64e-05	0.0001	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-DQB1—multiple sclerosis	1.63e-05	9.95e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.58e-05	9.67e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—VCAM1—multiple sclerosis	1.58e-05	9.67e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-DQA1—multiple sclerosis	1.58e-05	9.64e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—RRM1—multiple sclerosis	1.57e-05	9.62e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—MMP9—multiple sclerosis	1.57e-05	9.62e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—RPL5—multiple sclerosis	1.57e-05	9.6e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD86—multiple sclerosis	1.57e-05	9.58e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.54e-05	9.45e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.54e-05	9.43e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCL3—multiple sclerosis	1.54e-05	9.43e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD40LG—multiple sclerosis	1.54e-05	9.39e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD8A—multiple sclerosis	1.52e-05	9.29e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.51e-05	9.25e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—SLC11A1—multiple sclerosis	1.5e-05	9.2e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—TYK2—multiple sclerosis	1.5e-05	9.18e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CD4—multiple sclerosis	1.5e-05	9.16e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PTGER4—multiple sclerosis	1.48e-05	9.07e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-DQB1—multiple sclerosis	1.47e-05	9.02e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-B—multiple sclerosis	1.46e-05	8.94e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PGR—multiple sclerosis	1.46e-05	8.94e-05	CbGpPWpGaD
Sulfasalazine—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.46e-05	8.92e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CD86—multiple sclerosis	1.45e-05	8.84e-05	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—POMC—multiple sclerosis	1.44e-05	8.83e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—IL6—multiple sclerosis	1.44e-05	8.83e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.44e-05	8.82e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.44e-05	8.81e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD4—multiple sclerosis	1.44e-05	8.8e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CXCR3—multiple sclerosis	1.43e-05	8.76e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD86—multiple sclerosis	1.42e-05	8.69e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—IL6—multiple sclerosis	1.42e-05	8.69e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CD28—multiple sclerosis	1.42e-05	8.68e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.41e-05	8.6e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—STAT3—multiple sclerosis	1.4e-05	8.55e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCL3—multiple sclerosis	1.4e-05	8.55e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCR2—multiple sclerosis	1.39e-05	8.52e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD40LG—multiple sclerosis	1.39e-05	8.52e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Generic Transcription Pathway—MYC—multiple sclerosis	1.38e-05	8.44e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD8A—multiple sclerosis	1.38e-05	8.42e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.37e-05	8.38e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL2RA—multiple sclerosis	1.37e-05	8.37e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—BCHE—multiple sclerosis	1.36e-05	8.33e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CD4—multiple sclerosis	1.36e-05	8.31e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-A—multiple sclerosis	1.35e-05	8.28e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PTGER4—multiple sclerosis	1.34e-05	8.23e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-B—multiple sclerosis	1.32e-05	8.1e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PGR—multiple sclerosis	1.32e-05	8.1e-05	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—ALB—multiple sclerosis	1.32e-05	8.05e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IL6—multiple sclerosis	1.31e-05	8.01e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD4—multiple sclerosis	1.3e-05	7.98e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.3e-05	7.95e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CXCR3—multiple sclerosis	1.3e-05	7.95e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—TGFB1—multiple sclerosis	1.3e-05	7.93e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—IL6—multiple sclerosis	1.29e-05	7.88e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CD28—multiple sclerosis	1.29e-05	7.87e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CNR1—multiple sclerosis	1.29e-05	7.87e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CCR5—multiple sclerosis	1.28e-05	7.84e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.28e-05	7.84e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—MAPK1—multiple sclerosis	1.27e-05	7.78e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.27e-05	7.76e-05	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—IL6—multiple sclerosis	1.27e-05	7.75e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCR2—multiple sclerosis	1.26e-05	7.73e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—BCHE—multiple sclerosis	1.26e-05	7.72e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—HLA-A—multiple sclerosis	1.25e-05	7.64e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL2RA—multiple sclerosis	1.24e-05	7.59e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—TLR4—multiple sclerosis	1.24e-05	7.57e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-DRB1—multiple sclerosis	1.24e-05	7.56e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-A—multiple sclerosis	1.23e-05	7.51e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—BCHE—multiple sclerosis	1.21e-05	7.41e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—TNF—multiple sclerosis	1.21e-05	7.4e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CD28—multiple sclerosis	1.2e-05	7.34e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—ICAM1—multiple sclerosis	1.19e-05	7.26e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—APOE—multiple sclerosis	1.17e-05	7.14e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CNR1—multiple sclerosis	1.17e-05	7.13e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CXCL10—multiple sclerosis	1.16e-05	7.08e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD80—multiple sclerosis	1.14e-05	6.99e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—TLR4—multiple sclerosis	1.12e-05	6.87e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-DRB1—multiple sclerosis	1.12e-05	6.86e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.12e-05	6.83e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—ICAM1—multiple sclerosis	1.08e-05	6.58e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CD80—multiple sclerosis	1.05e-05	6.45e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—MAPK1—multiple sclerosis	1.05e-05	6.45e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CXCL10—multiple sclerosis	1.05e-05	6.42e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—APOE—multiple sclerosis	1.04e-05	6.37e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD80—multiple sclerosis	1.04e-05	6.34e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.02e-05	6.23e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CD86—multiple sclerosis	1.01e-05	6.19e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCL5—multiple sclerosis	9.96e-06	6.1e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—IL6—multiple sclerosis	9.76e-06	5.97e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—TYK2—multiple sclerosis	9.64e-06	5.9e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—BCHE—multiple sclerosis	9.62e-06	5.88e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—MAPK1—multiple sclerosis	9.55e-06	5.85e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SPP1—multiple sclerosis	9.23e-06	5.65e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CD86—multiple sclerosis	9.18e-06	5.62e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCL5—multiple sclerosis	9.04e-06	5.53e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—BCHE—multiple sclerosis	9.03e-06	5.53e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IFNG—multiple sclerosis	9.03e-06	5.52e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCR5—multiple sclerosis	8.98e-06	5.49e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—POMC—multiple sclerosis	8.94e-06	5.47e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—TYK2—multiple sclerosis	8.9e-06	5.45e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL2RA—multiple sclerosis	8.85e-06	5.41e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—TYK2—multiple sclerosis	8.74e-06	5.35e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD4—multiple sclerosis	8.72e-06	5.33e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CD86—multiple sclerosis	8.56e-06	5.24e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SPP1—multiple sclerosis	8.37e-06	5.12e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—APOE—multiple sclerosis	8.19e-06	5.01e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IFNG—multiple sclerosis	8.19e-06	5.01e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—APOE—multiple sclerosis	8.17e-06	5e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—ALB—multiple sclerosis	8.15e-06	4.99e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCR5—multiple sclerosis	8.14e-06	4.98e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—IL6—multiple sclerosis	8.1e-06	4.95e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL1B—multiple sclerosis	8.05e-06	4.93e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CD4—multiple sclerosis	8.05e-06	4.93e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL2RA—multiple sclerosis	8.02e-06	4.91e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL2—multiple sclerosis	8.02e-06	4.91e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD4—multiple sclerosis	7.91e-06	4.84e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CCR5—multiple sclerosis	7.59e-06	4.65e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—APOE—multiple sclerosis	7.59e-06	4.64e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—APOE—multiple sclerosis	7.41e-06	4.53e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HLA-A—multiple sclerosis	7.4e-06	4.53e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CD80—multiple sclerosis	7.38e-06	4.52e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—IL6—multiple sclerosis	7.34e-06	4.49e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL1B—multiple sclerosis	7.3e-06	4.47e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—APOE—multiple sclerosis	7.29e-06	4.46e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL2—multiple sclerosis	7.27e-06	4.45e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—POMC—multiple sclerosis	7.04e-06	4.31e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—POMC—multiple sclerosis	7.02e-06	4.29e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—APOE—multiple sclerosis	6.91e-06	4.23e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCL2—multiple sclerosis	6.86e-06	4.2e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—STAT3—multiple sclerosis	6.75e-06	4.13e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CD80—multiple sclerosis	6.7e-06	4.1e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—MYC—multiple sclerosis	6.64e-06	4.07e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—POMC—multiple sclerosis	6.52e-06	3.99e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ALB—multiple sclerosis	6.42e-06	3.93e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—POMC—multiple sclerosis	6.36e-06	3.89e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—POMC—multiple sclerosis	6.26e-06	3.83e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CD80—multiple sclerosis	6.25e-06	3.82e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TYK2—multiple sclerosis	6.23e-06	3.81e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—STAT3—multiple sclerosis	6.23e-06	3.81e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCL2—multiple sclerosis	6.22e-06	3.81e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—MAPK1—multiple sclerosis	6.14e-06	3.75e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—STAT3—multiple sclerosis	6.12e-06	3.75e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ALB—multiple sclerosis	5.94e-06	3.64e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MYC—multiple sclerosis	5.79e-06	3.54e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—APOE—multiple sclerosis	5.79e-06	3.54e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—TGFB1—multiple sclerosis	5.78e-06	3.54e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ALB—multiple sclerosis	5.71e-06	3.49e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MAPK1—multiple sclerosis	5.67e-06	3.47e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TYK2—multiple sclerosis	5.65e-06	3.46e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—MAPK1—multiple sclerosis	5.56e-06	3.4e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—APOE—multiple sclerosis	5.44e-06	3.33e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TYK2—multiple sclerosis	5.27e-06	3.23e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL2—multiple sclerosis	5.19e-06	3.17e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—POMC—multiple sclerosis	4.97e-06	3.04e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MMP9—multiple sclerosis	4.91e-06	3e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CD4—multiple sclerosis	4.77e-06	2.92e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL6—multiple sclerosis	4.72e-06	2.89e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL2—multiple sclerosis	4.7e-06	2.88e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—POMC—multiple sclerosis	4.67e-06	2.86e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ALB—multiple sclerosis	4.53e-06	2.77e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MMP9—multiple sclerosis	4.45e-06	2.72e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—STAT3—multiple sclerosis	4.36e-06	2.67e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—IL6—multiple sclerosis	4.35e-06	2.66e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL6—multiple sclerosis	4.28e-06	2.62e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ALB—multiple sclerosis	4.26e-06	2.6e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MYC—multiple sclerosis	4.06e-06	2.48e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TGFB1—multiple sclerosis	4.05e-06	2.48e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MAPK1—multiple sclerosis	3.97e-06	2.43e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—STAT3—multiple sclerosis	3.96e-06	2.42e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—STAT3—multiple sclerosis	3.69e-06	2.26e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MYC—multiple sclerosis	3.68e-06	2.25e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TGFB1—multiple sclerosis	3.67e-06	2.24e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MAPK1—multiple sclerosis	3.6e-06	2.2e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MYC—multiple sclerosis	3.43e-06	2.1e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TGFB1—multiple sclerosis	3.42e-06	2.09e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MAPK1—multiple sclerosis	3.36e-06	2.05e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL6—multiple sclerosis	3.05e-06	1.87e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL6—multiple sclerosis	2.76e-06	1.69e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IL6—multiple sclerosis	2.58e-06	1.58e-05	CbGpPWpGaD
